418 related articles for article (PubMed ID: 29948647)
1. The Kraken Wakes: induced EMT as a driver of tumour aggression and poor outcome.
Redfern AD; Spalding LJ; Thompson EW
Clin Exp Metastasis; 2018 Apr; 35(4):285-308. PubMed ID: 29948647
[TBL] [Abstract][Full Text] [Related]
2. TGF-β signaling and epithelial-mesenchymal transition in cancer progression.
Katsuno Y; Lamouille S; Derynck R
Curr Opin Oncol; 2013 Jan; 25(1):76-84. PubMed ID: 23197193
[TBL] [Abstract][Full Text] [Related]
3. Induction of metastasis, cancer stem cell phenotype, and oncogenic metabolism in cancer cells by ionizing radiation.
Lee SY; Jeong EK; Ju MK; Jeon HM; Kim MY; Kim CH; Park HG; Han SI; Kang HS
Mol Cancer; 2017 Jan; 16(1):10. PubMed ID: 28137309
[TBL] [Abstract][Full Text] [Related]
4. Insights into cancer metastasis from a clinicopathologic perspective: Epithelial-Mesenchymal Transition is not a necessary step.
Chui MH
Int J Cancer; 2013 Apr; 132(7):1487-95. PubMed ID: 22833228
[TBL] [Abstract][Full Text] [Related]
5. Roles of Dietary Phytoestrogens on the Regulation of Epithelial-Mesenchymal Transition in Diverse Cancer Metastasis.
Lee GA; Hwang KA; Choi KC
Toxins (Basel); 2016 May; 8(6):. PubMed ID: 27231938
[TBL] [Abstract][Full Text] [Related]
6. Epithelial-mesenchymal transition in carcinomas of the female genital tract.
Stewart CJ; McCluggage WG
Histopathology; 2013 Jan; 62(1):31-43. PubMed ID: 23240668
[TBL] [Abstract][Full Text] [Related]
7. The tumor microenvironment: An irreplaceable element of tumor budding and epithelial-mesenchymal transition-mediated cancer metastasis.
Li H; Xu F; Li S; Zhong A; Meng X; Lai M
Cell Adh Migr; 2016 Jul; 10(4):434-46. PubMed ID: 26743180
[TBL] [Abstract][Full Text] [Related]
8. Aberrant cancer metabolism in epithelial-mesenchymal transition and cancer metastasis: Mechanisms in cancer progression.
Huang R; Zong X
Crit Rev Oncol Hematol; 2017 Jul; 115():13-22. PubMed ID: 28602165
[TBL] [Abstract][Full Text] [Related]
9. Tumor microenvironment and noncoding RNAs as co-drivers of epithelial-mesenchymal transition and cancer metastasis.
Drak Alsibai K; Meseure D
Dev Dyn; 2018 Mar; 247(3):405-431. PubMed ID: 28691356
[TBL] [Abstract][Full Text] [Related]
10. Revisiting epithelial-mesenchymal transition in cancer metastasis: the connection between epithelial plasticity and stemness.
Liao TT; Yang MH
Mol Oncol; 2017 Jul; 11(7):792-804. PubMed ID: 28649800
[TBL] [Abstract][Full Text] [Related]
11. Proteomic analysis of ovarian cancer cells during epithelial-mesenchymal transition (EMT) induced by epidermal growth factor (EGF) reveals mechanisms of cell cycle control.
Grassi ML; Palma CS; Thomé CH; Lanfredi GP; Poersch A; Faça VM
J Proteomics; 2017 Jan; 151():2-11. PubMed ID: 27394697
[TBL] [Abstract][Full Text] [Related]
12. Emerging roles of exosomes during epithelial-mesenchymal transition and cancer progression.
Greening DW; Gopal SK; Mathias RA; Liu L; Sheng J; Zhu HJ; Simpson RJ
Semin Cell Dev Biol; 2015 Apr; 40():60-71. PubMed ID: 25721809
[TBL] [Abstract][Full Text] [Related]
13. MicroRNAs and epithelial-mesenchymal transition in prostate cancer.
Sekhon K; Bucay N; Majid S; Dahiya R; Saini S
Oncotarget; 2016 Oct; 7(41):67597-67611. PubMed ID: 27588490
[TBL] [Abstract][Full Text] [Related]
14. Targeting EMT in cancer: opportunities for pharmacological intervention.
Davis FM; Stewart TA; Thompson EW; Monteith GR
Trends Pharmacol Sci; 2014 Sep; 35(9):479-88. PubMed ID: 25042456
[TBL] [Abstract][Full Text] [Related]
15. Molecular Pathways Mediating Metastases to the Brain via Epithelial-to-Mesenchymal Transition: Genes, Proteins, and Functional Analysis.
Jeevan DS; Cooper JB; Braun A; Murali R; Jhanwar-Uniyal M
Anticancer Res; 2016 Feb; 36(2):523-32. PubMed ID: 26851006
[TBL] [Abstract][Full Text] [Related]
16. Long non-coding RNA regulation of epithelial-mesenchymal transition in cancer metastasis.
Xu Q; Deng F; Qin Y; Zhao Z; Wu Z; Xing Z; Ji A; Wang QJ
Cell Death Dis; 2016 Jun; 7(6):e2254. PubMed ID: 27277676
[TBL] [Abstract][Full Text] [Related]
17. Diverse pathways of epithelial mesenchymal transition related with cancer progression and metastasis and potential effects of endocrine disrupting chemicals on epithelial mesenchymal transition process.
Lee HM; Hwang KA; Choi KC
Mol Cell Endocrinol; 2017 Dec; 457():103-113. PubMed ID: 28042023
[TBL] [Abstract][Full Text] [Related]
18. Synergistic effects of particulate matter and substrate stiffness on epithelial-to-mesenchymal transition.
Barker TH; Dysart MM; Brown AC; Douglas AM; Fiore VF; Russell AG;
Res Rep Health Eff Inst; 2014 Nov; (182):3-41. PubMed ID: 25669020
[TBL] [Abstract][Full Text] [Related]
19. Epithelial-Mesenchymal Transition (EMT) as a Therapeutic Target.
Jonckheere S; Adams J; De Groote D; Campbell K; Berx G; Goossens S
Cells Tissues Organs; 2022; 211(2):157-182. PubMed ID: 33401271
[TBL] [Abstract][Full Text] [Related]
20. The therapeutic potential of targeting the epithelial-mesenchymal transition in cancer.
Ginnebaugh KR; Ahmad A; Sarkar FH
Expert Opin Ther Targets; 2014 Jul; 18(7):731-45. PubMed ID: 24758643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
